Dr. Roger Stanzel discusses how point-of-care testing with the
i-STAT System led to improvements in ACT result availability and quality at Queen Elizabeth II Healthcare Sciences Center in Halifax, Nova Scotia.
Fast and accurate measurement of activated clotting time (ACT) is essential during cardiopulmonary bypass (CPB) surgery to monitor the degree of heparin-induced anti-coagulation. Delayed or inaccurate ACT results can put patients at risk for thrombosis and haemorrhage.
Dr. Roger Stanzel is the Clinical Perfusion Lead and Perfusion Research Director for the Nova Scotia Health Authority in Halifax, Nova Scotia, Canada.
He is an Adjunct Professor in the departments of Surgery and Graduate Studies at Dalhousie University in Halifax and has published and lectured widely on topics related to perfusion and thrombosis in cardiac surgery. Dr. Stanzel holds a PhD from the Department of Biology at Queen’s University in Ontario, Canada.
Based on your current location, the content on this page may not be relevant for your country.